LANTUS® Basal Insulin Compared to NPH Insulin
In clinical studies, the glucose-lowering effect on a molar basis of LANTUS®
basal insulin is approximately the same as NPH insulin.
In euglycemic clamp studies in healthy subjects or in patients with type 1 diabetes,
the onset of action of LANTUS® was slower than NPH insulin.
LANTUS® is the only 24-hour insulin approved exclusively for use once a day1
The effect profile of LANTUS® basal insulin was relatively constant with no
pronounced peak and the duration of its effect was prolonged compared to NPH insulin.
- LANTUS® should be taken at the same time each day
Next: LANTUS® SoloSTAR®
Pen